Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3318077 | Pancreatology | 2010 | 5 Pages |
Abstract
Background/Aims: The secretin stimulation test is the principal diagnostic tool to identify Zollinger-Ellison syndrome (ZES). We investigated, by intra-individual comparison, which dose of secretin results in the highest diagnostic efficacy to identify the ZES. Methods: Fifty-seven paired secretin stimulation tests, using both 0.26 μg/kg and 0.78 μg/kg secretin, performed in 13 ZES patients and 12 controls, were analyzed and the findings confirmed in a validation cohort. Results: A gastrin increase of >100 ng/l was found to be the most sensitive and specific criterion for a positive test. Higher gastrin increases after 0.78 μg/kg compared to 0.26 μg/kg secretin contributed to a slightly more sensitive (82.9 vs. 80.5%) but less specific (68.8 vs. 81.3%) test. A validation cohort, with 98 tests using 0.26 μg/kg secretin in 21 ZES patients and 39 controls, provided similar results. In ZES patients with normal fasting serum gastrin levels (<100 ng/l), there was no diagnostic benefit from the use of a higher secretin dose. Conclusions: The 0.26 μg/kg secretin stimulation test has the best diagnostic efficacy for the ZES.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Patricia Kuiper, Izäk Biemond, Ad A. Masclee, Jan B. Jansen, Hein W. Verspaget, Cornelis B. Lamers,